To see the other types of publications on this topic, follow the link: Endocrine abnormalities.

Journal articles on the topic 'Endocrine abnormalities'

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'Endocrine abnormalities.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Osborn, Irene. "Endocrine Abnormalities." Anesthesiology Clinics of North America 5, no. 3 (1987): 521–29. http://dx.doi.org/10.1016/s0889-8537(21)00331-x.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

van Durme, Caroline MPG, Jérôme MH Kisters, Pieter van Paassen, Ronald W. van Etten, and Jan Willem Cohen Tervaert. "Multiple endocrine abnormalities." Lancet 378, no. 9790 (2011): 540. http://dx.doi.org/10.1016/s0140-6736(11)60831-3.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

VULLO, C., V. SANCTIS, M. KATZ, et al. "Endocrine Abnormalities in Thalassemia." Annals of the New York Academy of Sciences 612, no. 1 Sixth Cooley' (1990): 293–310. http://dx.doi.org/10.1111/j.1749-6632.1990.tb24317.x.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Williams, D. J. "Malakoplakia and endocrine abnormalities." Postgraduate Medical Journal 63, no. 745 (1987): 1007. http://dx.doi.org/10.1136/pgmj.63.745.1007.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Björntorp, Per. "Endocrine abnormalities of obesity." Metabolism 44 (September 1995): 21–23. http://dx.doi.org/10.1016/0026-0495(95)90315-1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Marinova, Elena, and Radina Dimitrova. "Endocrine abnormalities in thalassemia major." Varna Medical Forum 8, no. 1 (2019): 29. http://dx.doi.org/10.14748/vmf.v8i1.5795.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Peiris, Alan, and Ahmed Kissebah. "Endocrine Abnormalities in Morbid Obesity." Gastroenterology Clinics of North America 16, no. 3 (1987): 389–98. http://dx.doi.org/10.1016/s0889-8553(21)00303-4.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Shanks, Gabriella, Vinita Mishra, and Stanka Nikolova. "Endocrine abnormalities in lithium toxicity." Clinical Medicine 17, no. 5 (2017): 434–36. http://dx.doi.org/10.7861/clinmedicine.17-5-434.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Freudenthal, Bernard. "Endocrine abnormalities in lithium toxicity." Clinical Medicine 18, no. 1 (2018): 110.1–110. http://dx.doi.org/10.7861/clinmedicine.18-1-110.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Jain, Ankit, S. Ramakrishanan, and Rajesh Khadgawat. "Endocrine abnormalities in dilated cardiomyopathy." Journal of the Practice of Cardiovascular Sciences 1, no. 3 (2015): 247. http://dx.doi.org/10.4103/2395-5414.177235.

Full text
APA, Harvard, Vancouver, ISO, and other styles
11

Lawson, Elizabeth A., and Anne Klibanski. "Endocrine abnormalities in anorexia nervosa." Nature Clinical Practice Endocrinology & Metabolism 4, no. 7 (2008): 407–14. http://dx.doi.org/10.1038/ncpendmet0872.

Full text
APA, Harvard, Vancouver, ISO, and other styles
12

DONCKIER, J. E. "ECG abnormalities of endocrine origin." Heart 85, no. 6 (2001): 679. http://dx.doi.org/10.1136/heart.85.6.679.

Full text
APA, Harvard, Vancouver, ISO, and other styles
13

Douglas, R. H., and Norman Umphenour. "Endocrine Abnormalities and Hormonal Therapy." Veterinary Clinics of North America: Equine Practice 8, no. 1 (1992): 237–49. http://dx.doi.org/10.1016/s0749-0739(17)30478-9.

Full text
APA, Harvard, Vancouver, ISO, and other styles
14

Sklar, Charles A. "Craniopharyngioma: Endocrine Abnormalities at Presentation." Pediatric Neurosurgery 21, no. 1 (1994): 18–20. http://dx.doi.org/10.1159/000120856.

Full text
APA, Harvard, Vancouver, ISO, and other styles
15

Burra, Patrizia. "Liver abnormalities and endocrine diseases." Best Practice & Research Clinical Gastroenterology 27, no. 4 (2013): 553–63. http://dx.doi.org/10.1016/j.bpg.2013.06.014.

Full text
APA, Harvard, Vancouver, ISO, and other styles
16

Pelletier, F., A. Mirchi, FK Cayami, et al. "P.004 Endocrine and growth abnormalities in 4H leukodystrophy patients with a molecular diagnosis." Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques 43, S2 (2016): S22. http://dx.doi.org/10.1017/cjn.2016.110.

Full text
Abstract:
Background: 4H or POLR3-related leukodystrophy is an autosomal recessive disorder characterized by hypomyelination, hypodontia and hypogonadotropic hypogonadism caused by mutations in POLR3A, POLR3B and POLR1C. The endocrine abnormalities have never been systematically studied. Methods: A cross sectional international multicenter study was performed and the following variables were assessed: weight, height, head circumference, pubertal history, hormone levels and neurological and non-neurological features. Data was analyzed to determine whether there was a correlation between the presence of e
APA, Harvard, Vancouver, ISO, and other styles
17

Morshed, Md Shahed. "Endocrine and metabolic aspects of dengue syndrome." Journal of Association of Clinical Endocrinologist and Diabetologist of Bangladesh 2, no. 2 (2025): 66–70. https://doi.org/10.3329/jacedb.v2i2.78446.

Full text
Abstract:
Dengue virus infection is increasing in frequency as well as its complications. Profound/prolonged dengue shock syndrome causes metabolic acidosis leading to different metabolic and electrolyte abnormalities. Endocrine glands may be involved by shock, bleeding, and inflammation and may present with transient abnormalities in hormone levels. This unusual expanded dengue syndrome may require close follow up for proper management. Besides, diabetes mellitus and obesity are risk factors for severe dengue and mortality. This review article summarizes the endocrine and metabolic aspects of dengue in
APA, Harvard, Vancouver, ISO, and other styles
18

Verrotti, Alberto, Mariapaola Ciampani, Mariapina Pomilio, Giuseppe Latini, and Francesco Chiarelli. "Endocrine Abnormalities Induced by Antiepileptic Drugs." Current Pediatric Reviews 2, no. 1 (2006): 85–92. http://dx.doi.org/10.2174/157339606775518313.

Full text
APA, Harvard, Vancouver, ISO, and other styles
19

Kelner, Michael J., and Nicholas M. Alexander. "Endocrine Hormone Abnormalities in Amanita Poisoning." Journal of Toxicology: Clinical Toxicology 25, no. 1-2 (1987): 21–37. http://dx.doi.org/10.3109/15563658708992611.

Full text
APA, Harvard, Vancouver, ISO, and other styles
20

Mehr, A. J., B. M. Paulus, and K. T. Weber. "A VARIANT OF MULTIPLE ENDOCRINE ABNORMALITIES." Journal of Investigative Medicine 55, no. 1 (2007): S257. http://dx.doi.org/10.1097/00042871-200701010-00577.

Full text
APA, Harvard, Vancouver, ISO, and other styles
21

Leavey, Sean F., and William F. Weitzel. "Endocrine abnormalities in chronic renal failure." Endocrinology and Metabolism Clinics of North America 31, no. 1 (2002): 107–19. http://dx.doi.org/10.1016/s0889-8529(01)00006-8.

Full text
APA, Harvard, Vancouver, ISO, and other styles
22

El-Reshaid, Kamel A. M., Abass A. Hakim, Hana A. Hourani, and Mandalam S. Seshadri. "Endocrine Abnormalities in Patients with Amyloidosis." Renal Failure 16, no. 6 (1994): 725–30. http://dx.doi.org/10.3109/08860229409044902.

Full text
APA, Harvard, Vancouver, ISO, and other styles
23

Lawrence, Cara, Irene Hong-McAtee, Bryan Hall, et al. "Endocrine abnormalities in townes-brocks syndrome." American Journal of Medical Genetics Part A 161, no. 9 (2013): 2266–73. http://dx.doi.org/10.1002/ajmg.a.36104.

Full text
APA, Harvard, Vancouver, ISO, and other styles
24

Kuczera, Piotr, Marcin Adamczak, and Andrzej Wiecek. "Endocrine Abnormalities in Patients with Chronic Kidney Disease." PRILOZI 36, no. 2 (2015): 109–18. http://dx.doi.org/10.1515/prilozi-2015-0059.

Full text
Abstract:
Abstract In patients with chronic kidney disease the alterations of the endocrine system may arise from several causes. The kidney is the site of degradation as well as synthesis of many different hormones. Moreover, a number of concomitant pathological conditions such as inflammation, metabolic acidosis and malnutrition may participate in the pathogenesis of endocrine abnormalities in this group of patients. The most pronounced endocrine abnormalities in patients with chronic kidney disease are the deficiencies of: calcitriol, testosterone, insulin-like growth factor and, erythropoietin (EPO)
APA, Harvard, Vancouver, ISO, and other styles
25

Rosenfeld, Cheryl R., and S. Sethu K. Reddy. "Endocrine and Metabolic Manifestations of HIV Infection and AIDS." Journal of Intensive Care Medicine 16, no. 4 (2001): 161–68. http://dx.doi.org/10.1177/088506660101600401.

Full text
Abstract:
Since the first descriptions of acquired immune deficiency syndrome (AIDS) and human immunodeficiency virus (HIV), a great deal of knowledge has been accumulated on how these entities interact with the endocrine system. Recently new information has been received on autoimmune dysregulation causing thyroid abnormalities after highly active antiretroviral therapy (HAART), as well as metabolic dysregulation occurring in the setting of protease inhibitors. We review the pathophysiologic abnormalities of the endocrine systems due to HIV infection as well as the endocrine effects of drugs commonly u
APA, Harvard, Vancouver, ISO, and other styles
26

Newman, Connie B., Michael J. Blaha, Jeffrey B. Boord, et al. "Lipid Management in Patients with Endocrine Disorders: An Endocrine Society Clinical Practice Guideline." Journal of Clinical Endocrinology & Metabolism 105, no. 12 (2020): 3613–82. http://dx.doi.org/10.1210/clinem/dgaa674.

Full text
Abstract:
Abstract Objective This guideline will provide the practicing endocrinologist with an approach to the assessment and treatment of dyslipidemia in patients with endocrine diseases, with the objective of preventing cardiovascular (CV) events and triglyceride-induced pancreatitis. The guideline reviews data on dyslipidemia and atherosclerotic cardiovascular disease (ASCVD) risk in patients with endocrine disorders and discusses the evidence for the correction of dyslipidemia by treatment of the endocrine disease. The guideline also addresses whether treatment of the endocrine disease reduces ASCV
APA, Harvard, Vancouver, ISO, and other styles
27

Stosel, Helen, та Glenn D. Braunstein. "Endocrine Abnormalities Associated with Langerhansʼ Cell Histiocytosis". Endocrinologist 1, № 6 (1991): 393–98. http://dx.doi.org/10.1097/00019616-199112000-00007.

Full text
APA, Harvard, Vancouver, ISO, and other styles
28

Schoeters, Greet, Elly Den Hond, Willem Dhooge, Nik Van Larebeke, and Marike Leijs. "Endocrine Disruptors and Abnormalities of Pubertal Development." Basic & Clinical Pharmacology & Toxicology 102, no. 2 (2008): 168–75. http://dx.doi.org/10.1111/j.1742-7843.2007.00180.x.

Full text
APA, Harvard, Vancouver, ISO, and other styles
29

SAITO, Shiro. "Pathophysiology and Gene Abnormalities of Endocrine Tumors." Folia Endocrinologica Japonica 68, no. 12 (1992): 1225–39. http://dx.doi.org/10.1507/endocrine1927.68.12_1225.

Full text
APA, Harvard, Vancouver, ISO, and other styles
30

Franchini, Massimo, Giuseppe Lippi, Franco Manzato, Pier Paolo Vescovi, and Giovanni Targher. "Hemostatic abnormalities in endocrine and metabolic disorders." European Journal of Endocrinology 162, no. 3 (2010): 439–51. http://dx.doi.org/10.1530/eje-09-0958.

Full text
Abstract:
The hemostatic balance is a complex system where the delicate equilibrium is regulated by several factors, including hormones. This review summarizes current knowledge of the effects of most frequent endocrine and metabolic diseases (such as hypothyroidism, hyperthyroidism, Cushing's syndrome, GH-related pituitary dysfunctions, pituitary prolactin-producing adenomas, polycystic ovary syndrome, primary hyperparathyroidism, and metabolic syndrome) on coagulation and fibrinolysis. Overt hypothyroidism appears to be associated with a bleeding tendency, whereas all other endocrine diseases appear t
APA, Harvard, Vancouver, ISO, and other styles
31

Giri, Neelam, Dalia L. Batista, Blanche P. Alter, and Constantine A. Stratakis. "Endocrine Abnormalities in Patients with Fanconi Anemia." Journal of Clinical Endocrinology & Metabolism 92, no. 7 (2007): 2624–31. http://dx.doi.org/10.1210/jc.2007-0135.

Full text
Abstract:
Abstract Background: Fanconi anemia (FA) is an inherited disorder with chromosomal instability, bone marrow failure, developmental defects, and a predisposition to cancer. Systematic and comprehensive endocrine function data in FA are limited. Objective: We studied a cohort of FA patients enrolled in the National Cancer Institute’s Inherited Bone Marrow Failure Syndrome study. Study Design and Patients: Retrospective review of the medical records of 45 FA patients (ages 2–49 yr), 23 of whom were intensively evaluated at the National Institutes of Health. Anthropometric measurements, GH, IGF-I,
APA, Harvard, Vancouver, ISO, and other styles
32

Franceschini, R., G. L. Tenconi, F. Zoppoli, and T. Barreca. "Endocrine abnormalities and outcome of ischaemic stroke." Biomedicine & Pharmacotherapy 55, no. 8 (2001): 458–65. http://dx.doi.org/10.1016/s0753-3322(01)00086-5.

Full text
APA, Harvard, Vancouver, ISO, and other styles
33

Hörl, W. H., W. Riegel, C. Wanner, et al. "Endocrine and metabolic abnormalities following kidney transplantation." Klinische Wochenschrift 67, no. 17 (1989): 907–18. http://dx.doi.org/10.1007/bf01717348.

Full text
APA, Harvard, Vancouver, ISO, and other styles
34

Polgreen, Lynda, Melissa Plog, Paul Orchard, Bradley Miller, Anna Petryk, and Chester B. Whitley. "40 Endocrine abnormalities in patients with mucopolysaccharidoses." Molecular Genetics and Metabolism 92, no. 4 (2007): 20–21. http://dx.doi.org/10.1016/j.ymgme.2007.08.045.

Full text
APA, Harvard, Vancouver, ISO, and other styles
35

Rajiwade, Siddhesh R., Haritha Sagili, R. Soundravally, and L. Subitha. "Endocrine Abnormalities in Adolescents with Menstrual Disorders." Journal of Obstetrics and Gynecology of India 68, no. 1 (2017): 58–64. http://dx.doi.org/10.1007/s13224-017-1035-y.

Full text
APA, Harvard, Vancouver, ISO, and other styles
36

Wacharasindhu, S., U. Asawutmangkul, and S. Srivuthana. "Endocrine Abnormalities in Patients with Frontoethmoidal Encephalomeningocele." Hormone Research in Paediatrics 64, no. 2 (2005): 64–67. http://dx.doi.org/10.1159/000087691.

Full text
APA, Harvard, Vancouver, ISO, and other styles
37

Oerter, Karen E., Theodore C. Friedman, Hans C. Anderson, and Fernando G. Cassorla. "Familial syndrome of endocrine and neuroectodermal abnormalities." American Journal of Medical Genetics 44, no. 4 (1992): 487–91. http://dx.doi.org/10.1002/ajmg.1320440421.

Full text
APA, Harvard, Vancouver, ISO, and other styles
38

Bongsebandhu-phubhakdi, Chansuda, Therdpong Tempark, and Vichit Supornsilpchai. "Endocrine manifestations of PHACE syndrome." Journal of Pediatric Endocrinology and Metabolism 32, no. 8 (2019): 797–802. http://dx.doi.org/10.1515/jpem-2019-0126.

Full text
Abstract:
Abstract PHACE syndrome is an uncommon disorder of posterior fossa anomalies, cervicofacial infantile hemangiomas, arterial anomalies, cardiac defects, eye anomalies, and midline/ventral defects. Endocrine abnormalities including hypopituitarism and ectopic thyroid were rarely described. In this article we review occurrence, onset, presenting symptoms, hormonal treatments and outcomes of all endocrine abnormalities in PHACE syndrome. Eleven of 20 (55%) had hypothalamic-pituitary dysfunction and 10 of 20 (50%) had thyroid dysgenesis. A thorough understanding of the endocrine manifestations is i
APA, Harvard, Vancouver, ISO, and other styles
39

Nonglait, Phibakordor L., Srivenkata Madhu, Nishant Raizada, Amitesh Aggarwal, Rafat Ahmed, and Mohammad Aslam. "Abnormalities of Endocrine Function Tests in COVID-19-Recovered Individuals." Indian Journal of Endocrinology and Metabolism 29, no. 3 (2025): 325–31. https://doi.org/10.4103/ijem.ijem_32_25.

Full text
Abstract:
Abstract Introduction: Impact of COVID-19 on endocrine system due to the widespread distribution of Angiotensin Converting Enzyme-2 (ACE2) receptors in different endocrine organs of the body has been shown in several studies. However, most of these studies were in the setting of acute COVID-19. The present study was planned to comprehensively evaluate endocrine abnormalities in COVID-19-recovered individuals. Methods: Eighty-three COVID-19-recovered individuals were recruited 8-20 weeks following the recovery. They were further stratified according to disease severity as defined by the Indian
APA, Harvard, Vancouver, ISO, and other styles
40

Hill, J., C. Elliott, and I. Colquhoun. "Audiological, vestibular and radiological abnormalities in Kallman's syndrome." Journal of Laryngology & Otology 106, no. 6 (1992): 530–34. http://dx.doi.org/10.1017/s0022215100120067.

Full text
Abstract:
AbstractKallman's syndrome is a multifaceted congenital disorder with predominantly endocrine abnormalities. We have characterized the associated mixed hearing loss and identified consistent radiological evidence of abnormal temporal bone anatomy. Abnormal labyrinthine morphology is accompanied by a complete absence of response to vestibular stimulation with caloric or rotational chair testing.The endocrine abnormalities are correctable and Kallman's syndrome is a diagnosis worthy of consideration when assessing children with congenital hearing loss.
APA, Harvard, Vancouver, ISO, and other styles
41

Rattan, Saniya, Changqing Zhou, Catheryne Chiang, Sharada Mahalingam, Emily Brehm, and Jodi A. Flaws. "Exposure to endocrine disruptors during adulthood: consequences for female fertility." Journal of Endocrinology 233, no. 3 (2017): R109—R129. http://dx.doi.org/10.1530/joe-17-0023.

Full text
Abstract:
Endocrine disrupting chemicals are ubiquitous chemicals that exhibit endocrine disrupting properties in both humans and animals. Female reproduction is an important process, which is regulated by hormones and is susceptible to the effects of exposure to endocrine disrupting chemicals. Disruptions in female reproductive functions by endocrine disrupting chemicals may result in subfertility, infertility, improper hormone production, estrous and menstrual cycle abnormalities, anovulation, and early reproductive senescence. This review summarizes the effects of a variety of synthetic endocrine dis
APA, Harvard, Vancouver, ISO, and other styles
42

Iguchi, Taisen, and Tomomi Sato. "Endocrine Disruption and Developmental Abnormalities of Female Reproduction1." American Zoologist 40, no. 3 (2000): 402–11. http://dx.doi.org/10.1668/0003-1569(2000)040[0402:edadao]2.0.co;2.

Full text
APA, Harvard, Vancouver, ISO, and other styles
43

Diegel, Cassandra R., Steven Hann, Ugur M. Ayturk, et al. "An osteocalcin-deficient mouse strain without endocrine abnormalities." PLOS Genetics 16, no. 5 (2020): e1008361. http://dx.doi.org/10.1371/journal.pgen.1008361.

Full text
APA, Harvard, Vancouver, ISO, and other styles
44

Brinker, Mark R., Daniel P. O??Connor, Yomna T. Monla, and Thomas P. Earthman. "Metabolic and Endocrine Abnormalities in Patients With Nonunions." Journal of Orthopaedic Trauma 21, no. 8 (2007): 557–70. http://dx.doi.org/10.1097/bot.0b013e31814d4dc6.

Full text
APA, Harvard, Vancouver, ISO, and other styles
45

&NA;. "Undiagnosed Metabolic and Endocrine Abnormalities May Explain Nonunions." Lippincott's Bone and Joint Newsletter 14, no. 1 (2008): 8–9. http://dx.doi.org/10.1097/01.bonej.0000305503.91042.37.

Full text
APA, Harvard, Vancouver, ISO, and other styles
46

Iguchi, Taisen, and Tomomi Sato. "Endocrine Disruption and Developmental Abnormalities of Female Reproduction." American Zoologist 40, no. 3 (2000): 402–11. http://dx.doi.org/10.1093/icb/40.3.402.

Full text
APA, Harvard, Vancouver, ISO, and other styles
47

Brinker, Mark R., Daniel P. OʼConnor, Yomna T. Monla, and Thomas P. Earthman. "Metabolic and endocrine abnormalities in patients with nonunions." Current Orthopaedic Practice 19, no. 4 (2008): 430–42. http://dx.doi.org/10.1097/bco.0b013e32830b8711.

Full text
APA, Harvard, Vancouver, ISO, and other styles
48

Suzuki, T., H. Sasano, T. Sawai, et al. "Small Adrenocortical Tumors without Apparent Clinical Endocrine Abnormalities." Pathology - Research and Practice 188, no. 7 (1992): 883–89. http://dx.doi.org/10.1016/s0344-0338(11)80248-7.

Full text
APA, Harvard, Vancouver, ISO, and other styles
49

Elovic, Elie, Hima S. Doppalapudi, Michelle Miller, et al. "Endocrine Abnormalities and Fatigue After Traumatic Brain Injury." Journal of Head Trauma Rehabilitation 21, no. 5 (2006): 426–27. http://dx.doi.org/10.1097/00001199-200609000-00044.

Full text
APA, Harvard, Vancouver, ISO, and other styles
50

Haimovici, Robert, Shimon Rumelt, and James Melby. "Endocrine abnormalities in patients with central serous chorioretinopathy." Ophthalmology 110, no. 4 (2003): 698–703. http://dx.doi.org/10.1016/s0161-6420(02)01975-9.

Full text
APA, Harvard, Vancouver, ISO, and other styles
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!